Hormonal Management of Complete Androgen Insensitivity Syndrome from Adolescence Onward

  title={Hormonal Management of Complete Androgen Insensitivity Syndrome from Adolescence Onward},
  author={Silvano Bertelloni and Eleonora Dati and Giampiero I. Baroncelli and Olaf Hiort},
  journal={Hormone Research in Paediatrics},
  pages={428 - 433}
Complete androgen insensitivity syndrome (CAIS) represents a main disorder of sex development. Women with CAIS may have their gonads removed before, during or after adolescence, thus requiring hormonal replacement therapy to induce puberty and/or maintain secondary sexual characteristics, to optimize bone mass accrual, and to promote physical and social well-being. Usually estrogens are used for this purpose, but formulations and doses should be better defined in multicentric prospective… 

Tables from this paper

Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When?

For women with CAIS who wish to keep their gonads, a biannual screening program which has to be evaluated in a prospective multi-center trial is proposed.

Gonadal Surgery in Complete Androgen Insensitivity Syndrome: A Debate

Recommendations for gonadal removal in women living with CAIS vary in literature, and literature indications range from “the testes should be removed as soon as they are discovered” to “support leaving the testes in until after puberty has been completed and then either removing them or instituting a careful monitoring process for the early detection of seminoma".

Complete Androgen Insensitivity Syndrome: From Bench to Bed

Basic research will lead to the consideration of new issues to improve long-term well-being (such as bone health, immune and metabolic aspects and cardiovascular risk).

Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS)

Complete androgen insensitivity syndrome (CAIS) is an X-linked recessive genetic disorder resulting from maternally inherited or de novo mutations involving the androgen receptor gene, situated in

Sex hormone replacement in disorders of sex development.

Few sound evidence-based data are available to guide HRT administration at puberty and in adulthood in individuals with DSD, but recent data and new formulations may give better perspectives for the future.

Update on the Pathophysiology and Risk Factors for the Development of Malignant Testicular Germ Cell Tumors in Complete Androgen Insensitivity Syndrome

In order to provide optimal counseling and follow-up of women with CAIS, insight in the mechanisms underlying TGCT development in androgen insensitivity syndrome (AIS), data regarding the incidence of TGCT in AIS adults specifically, and an overview of existing and novel screening tools for in situ and invasive neoplastic lesions are crucial.

Androgen Insensitivity Syndrome

Characteristic Features of Reproductive Hormone Profiles in Late Adolescent and Adult Females with Complete Androgen Insensitivity Syndrome

Little is known about gonadotropins and sex steroid levels in postpubertal women with complete androgen insensitivity syndrome (CAIS). In order to define reproductive hormone profiles in women with



Disorders of sex development: Hormonal management in adolescence

The optimal regimens for sex steroid substitutive therapy in subjects with DSD should be better defined in multi-center prospective studies.

Hormonal therapies for individuals with intersex conditions: protocol for use.

A vigorous debate about ethical aspects of current medical practices relating to intersex conditions has been waged for the last 7 years between certain patient advocacy organizations and the medical profession, and is expected to continue for some time.

Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.

The results suggest that very low-dose parenteral estradiol permits relatively age-appropriate feminization without interfering with the effect of GH on the enhancement of height potential.

Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls.

It is concluded that in normal girls, the pubertal growth spurt also results from the action of estrogens rather than of adrenal androgens, and physiologic estrogen replacement in hypogonadal females should be started at a bone age of about 11 years, and should not be delayed in the hope of achieving a greater mature height.

Psychosexual functioning in women with complete testicular feminization: is androgen replacement therapy preferable to estrogen?

It is found that androgen therapy is preferable to estrogen in gonadectomized women with complete testicular feminization with regard to psychosexual functioning, but not on coitus, masturbation, sexual thoughts, scores on desire for bodily contact, and on attention for physical appearance.

Androgen resistance.

  • I. HughesA. Deeb
  • Biology, Medicine
    Best practice & research. Clinical endocrinology & metabolism
  • 2006

Puberty in disorders of somatosexual differentiation.

This review focuses not only on the molecular impact of sex steroid action, but also view current opinions and studies on the gender development of the intersex patient during puberty.

Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.

Taller stature in late gonadectomised CAIS women suggests an oestrogen deficiency in these women prior to gonadectomy, and increased lower to upper body ratio in GD(XY) women compared with the other groups implies that these subjects have the greatest degree of oestrogens deficiency in puberty.

Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.

Data suggest that the route of delivery of estrogen does not adversely affect these metabolic effects of GH in young girls with Turner syndrome, and neither oral nor TD estrogen adversely affected rates of protein turnover, lipolysis, and lipid oxidation rates or plasma lipids, fibrinogen, or fasting insulin concentrations.

Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.

In girls with TS, TD E2 resulted in faster bone accrual at the spine and increased uterine growth compared with conjugated oral estrogen and this pilot study provides preliminary information for optimizing estrogen replacement in this population.